期刊语言：英语

出版地区：英国

万维提示

1、投稿方式：在线投稿。

2、期刊网址：

https://infectagentscancer.biomedcentral.com/

https://link.springer.com/journal/13027/volumes-and-issues

3、投稿网址：https://www.editorialmanager.com/iaac

4、期刊刊期：年刊，一年出版1期。

2021年8月17日星期二

投稿须知【官网信息】

Infectious Agents and Cancer

Submission guidelines

Our 3-step submission process

 Before you submit

Now you’ve identified a journal to submit to, there are a few things you should be familiar with before you submit.

Make sure you are submitting to the most suitable journal - Aims and scope

Understand the costs and funding options - Fees and funding

Make sure your manuscript is accurate and readable - Language editing services

Understand the copyright agreement - Copyright

 Ready to submit

To give your manuscript the best chance of publication, follow these policies and formatting guidelines.

General formatting rules for all article types - Preparing your manuscript

Make sure your submission is complete - Prepare supporting information

Copyright and license agreement - Conditions of publication

Read and agree to our Editorial Policies - Editorial policies

 Submit and promote

After acceptance, we provide support so your article gains maximum impact in the scientific community and beyond.

Please note that manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party.

Who decides whether my work will be accepted? - Peer-review policy

Want to submit to a different journal? - Manuscript transfers

Spreading the word - Promoting your publication

Submit manuscript

Aims and scope

Infectious Agents and Cancer is an open access, peer-reviewed online journal that encompasses all aspects of basic, clinical, epidemiological and translational research providing an insight into the association between chronic infections and cancer.

The journal welcomes submissions in the pathogen-related cancer areas and other related topics, in particular:

• HPV and anogenital cancers, as well as head and neck cancers;

• EBV and Burkitt lymphoma;

• HCV/HBV and hepatocellular carcinoma as well as lymphoproliferative diseases;

• HHV8 and Kaposi sarcoma;

• HTLV and leukemia;

• Cancers in Low- and Middle-income countries.

The link between infection and cancer has become well established over the past 50 years, and infection-associated cancer contribute up to 16% of cancers in developed countries and 33% in less developed countries.

Preventive vaccines have been developed for only two cancer-causing viruses, highlighting both the opportunity to prevent infection-associated cancers by vaccination and the gaps that remain before vaccines can be developed for other cancer-causing agents. These gaps are due to incomplete understanding of the basic biology, natural history, epidemiology of many of the pathogens that cause cancer, the mechanisms they exploit to cause cancer, and how to interrupt progression to cancer in human populations. Early diagnosis or identification of lesions at high risk of progression represent the current most critical research area of the field supported by recent advances in genomics and proteomics technologies.

Moreover “omics” is contributing to and accelerating the discovery not only of novel pathogens, but of genetic predisposition as the genetic make-up of organisms and individuals is unraveled. The hunt for molecular signatures of cancer causation, early cancer, or cancer Achilles heels promises new ways to practice precision medicine and public health. The explosion of knowledge in tumor genomics, tumor biology, targeted therapies, gene-environment interactions, immunology and immunotherapy needs a space for robust and vigorous debate.

Infectious Agents and Cancer covers all these areas of biomedical research and any other topics pertinent to the development of preventive strategies, innovative diagnostic and biomolecular methodologies, promising therapeutic strategies for chronic infections and cancer. Immunotherapeutic strategies will include: profiling and activation of dendritic cells; reactivation of the immune system; breaking immune tolerance; modulation of the immune system by cytokines and drug delivery systems.

……

更多详情：

https://infectagentscancer.biomedcentral.com/submission-guidelines